Skip to main content

Analysing Dose Parameters of Radiation Therapy Treatment Planning and Estimation of Their Influence on Secondary Cancer Risks

  • Conference paper
  • First Online:
Bioinformatics and Biomedical Engineering (IWBBIO 2023)

Abstract

Breast Cancer is no longer considered a death sentence and the number of patients receiving radiotherapy is increasing every year. Advancements in RT technology allow more accurate and accumulated delivery of radiation significantly reducing the risk of side effects. The use of these techniques has led to better clinical outcomes and significantly increased long-term survival rates. Therefore, secondary cancer risk after breast conserving therapy is becoming more important. In this study, we estimate the risks of developing a solid second cancer after radiotherapy of breast cancer using the concept of organ equivalent dose (OED).

Eight breast cancer patients were retrospectively selected for this study. Three-dimensional conformal radiotherapy (3DCRT), intensity modulated radiotherapy (IMRT), and volumetric modulated arc therapy (VMAT) were planned to deliver a prescribed dose. Differential dose volume histograms (dDVHs) were created and the OEDs calculated. Secondary cancer risks of ipsilateral, contralateral lung and thyroid gland were estimated using linear, linear-exponential and plateau models.

The highest interest of our study was the evaluation of secondary cancer risk for the organs at risk (OAR), which are located far from the treatment region and are very sensitive to radiation exposure. Our results showed very high secondary cancer excess absolute risk (EAR) values for IMRT and VMAT compared with 3DCRT. It has to be noted, that a significant reduction of the EARs for the contralateral lung, ipsilateral lung and thyroid gland was observed in all dose–response models.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abo-Madyan, Y., et al.: Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer. Radiother. Oncol. 110(3), 471–476 (2014). https://doi.org/10.1016/j.radonc.2013.12.002

  2. Bartkowiak, D., et al.: Second cancer after radiotherapy, 1981–2007. Radiother. Oncol. 105(1), 122–126 (2011). https://doi.org/10.1016/j.radonc.2011.09.013

  3. Bhatti, P., et al.: Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat. Res. 174(6), 741–752. (2010). https://doi.org/10.1667/RR2240.1

  4. Biegon, A., Cohen, S., Franceschi, D.: Modulation of secondary cancer risks from radiation exposure by sex, age and gonadal hormone status: progress, opportunities and challenges. J. Pers. Med. 12(5), 725 (2022). https://doi.org/10.3390/jpm12050725

  5. Chen, S.N., Ramachandran, P., Deb, P.: Dosimetric comparative study of 3DCRT, IMRT, VMAT, Ecomp, and hybrid techniques for breast radiation therapy. Radiat. Oncol. J. 38(4), 270–281 (2022). https://doi.org/10.3857/roj.2020.00619

  6. Clarke, M., et al.: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503), 2087–2106 (2005). https://doi.org/10.1016/S0140-6736(05)67887-7

  7. Dayes, I.S., et al.: Cross-border referral for early breast cancer: an analysis of radiation fractionation patterns. Curr. Oncol. 13(4), 124–129 (2006)

    Google Scholar 

  8. Elezaby, M., et al.: BRCA mutation carriers: breast and ovarian cancer screening guidelines and imaging considerations. Radiology 291(3), 554–569 (2019). https://doi.org/10.1148/radiol.2019181814

  9. Fogliata, A., Nicolini, G., Alber, M., et al.: IMRT for breast: a planning study. Radiother. Oncol. 76(3), 300–310 (2005). https://doi.org/10.1016/j.radonc.2005.08.004

  10. Grantzau, T., Thomsen, M.S., Væth, M., Overgaard, J.: Risk of second primary lung cancer in women after radiotherapy for breast cancer. Radiother. Oncol. 111(3), 366–373 (2014). https://doi.org/10.1016/j.radonc.2014.05.004

  11. Hall, E.J.: Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int. J. Radiat. Oncol. Biol. Phys. 65(1), 1–7 (2006). https://doi.org/10.1016/j.ijrobp.2006.01.027

  12. Inskip, P.D., et al.: Radiation-related new primary solid cancers in the childhood cancer survivor study: comparative radiation dose response and modification of treatment effects. Int. J. Radiat. Oncol. Biol. Phys. 94(4), 800–807 (2016). https://doi.org/10.1016/j.ijrobp.2015.11.046

  13. Kara, F.G., Haydaroglu, A., Eren, H., Kitapcioglu, G.: Comparison of different techniques in breast cancer radiotherapy planning. J. Breast Health 10(2), 83–87 (2014). https://doi.org/10.5152/tjbh.2014.1772

    Article  PubMed  PubMed Central  Google Scholar 

  14. Long, Q., Wang, Y., Che, G.: Primary lung cancer after treatment for breast cancer. Int. J. Women’s Health 13, 1217–1225 (2021). https://doi.org/10.2147/IJWH.S338910

  15. Moran, M.S., Schnitt, S.J., Giuliano, A.E., et al.: Society of surgical oncology-American society for radiation oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Int. J. Radiat, Oncol, Biol. Phys. 88(3), 553–564 (2014). https://doi.org/10.1016/j.ijrobp.2013.11.012

  16. National Academy of Sciences: Committee on the Biological Effects Radiation: BEIR VII Phase 2. National Academies Press, Washington, DC (2005)

    Google Scholar 

  17. Preston, D.L., et al.: Solid cancer incidence in atomic bomb survivors: 1958–1998. Radiat. Res. 168(1), 1–64 (2007). https://doi.org/10.1667/RR0763.1

  18. Rebecca, M.H., Sarah, B.S., Kry, S.F., Derek, Z.Y.: Accuracy of out-of-field dose calculations by a commercial treatment planning system. Phys. Med. Biol. 55(23), 6999–7008 (2010). https://doi.org/10.1088/0031-9155/55/23/S03

  19. Ronckers, C.M., et al.: Thyroid cancer in childhood cancer survivors: a detailed evaluation of radiation dose response and its modifiers. Radiat. Res. 166(4), 618–28 (2006). https://doi.org/10.1667/RR3605.1

  20. Schneider, U., Kaser-Hotz, B.: Radiation risk estimates after radiotherapy: application of the organ equivalent dose concept to plateau dose–response relationships. Radiat. Environ. Biophys. 44(3), 235–239 (2005). https://doi.org/10.1007/s00411-005-0016-1

  21. Schneider, U., Lomax, A., Timmermann, B.: Second cancers in children treated with modern radiotherapy techniques. Radiother. Oncol. 89(2), 135–140 (2008). https://doi.org/10.1016/j.radonc.2008.07.017

    Article  PubMed  Google Scholar 

  22. Schneider, U., Sumila, M., Robotka, J.: Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy. Theor. Biol. Med. Model. 8, 27 (2011). https://doi.org/10.1186/1742-4682-8-27

    Article  PubMed  PubMed Central  Google Scholar 

  23. Schneider, U., Walsh, L.: Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy. Radiat. Environ. Biophys. 47(2), 253–263 (2008). https://doi.org/10.1007/s00411-007-0151-y

    Article  PubMed  Google Scholar 

  24. Schneider, U., Zwahlen, D., Ross, D., Kaser-Hotz, B.: Estimation of radiation induced cancer from three-dimensional dose distributions: concept of organ equivalent dose. Int. J. Radiat. Oncol. Biol. Phys. 61(5), 1510–1515 (2005). https://doi.org/10.1016/j.ijrobp.2004.12.040

    Article  PubMed  Google Scholar 

  25. ICRP: The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann. ICRP 37(2–4) (2007)

    Google Scholar 

  26. Thompson, D.E., et al.: Cancer incidence in atomic bomb survivors. Part II: Solid Tumors, 1958–1987. Radiat. Res. 137(2), S17–S67 (1994). https://doi.org/10.2307/3578892

    Article  CAS  PubMed  Google Scholar 

  27. Effects of ionizing radiation. UNSCEAR 2006 Report to the General Assembly with Scientific Annex United Nations, New York (2006)

    Google Scholar 

  28. Van Leeuwen, F.E., Klokman, W.J., Veer, M.B.V.T., et al.: Long-term risk of second malignancy in survivors of Hodgkin’s disease treated during adolescence or young adulthood. J. Clin. Oncol. 18(3), 487–497 (2000). https://doi.org/10.1200/JCO.2000.18.3.487

    Article  PubMed  Google Scholar 

  29. Verhaegen, F., Seuntjens, J.: Monte Carlo modelling of external radiotherapy photon beams. Phys. Med. Biol. 48(21), R107 (2003). https://doi.org/10.1088/0031-9155/48/21/r01

    Article  CAS  PubMed  Google Scholar 

  30. Zwahlen, D.R., Ruben, J.D., Jones, P., Gagliardi, F., Millar, J.L., Schneider, U.: Effect of intensity modulated pelvic radiotherapy on second cancer risk in the postoperative treatment of endometrial and cervical cancer. Int. J. Radiat. Oncol. Biol. Phys. 74, 539–545 (2009). https://doi.org/10.1016/j.ijrobp.2009.01.051

    Article  PubMed  Google Scholar 

Download references

Aknowledgement

This work was supported by Georgian Technical University.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lily Petriashvili .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Petriashvili, L., Khomeriki, I., Topeshashvili, M., Lominadze, T., Shanidze, R., Osepashvili, M. (2023). Analysing Dose Parameters of Radiation Therapy Treatment Planning and Estimation of Their Influence on Secondary Cancer Risks. In: Rojas, I., Valenzuela, O., Rojas Ruiz, F., Herrera, L.J., Ortuño, F. (eds) Bioinformatics and Biomedical Engineering. IWBBIO 2023. Lecture Notes in Computer Science(), vol 13919. Springer, Cham. https://doi.org/10.1007/978-3-031-34953-9_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-34953-9_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-34952-2

  • Online ISBN: 978-3-031-34953-9

  • eBook Packages: Computer ScienceComputer Science (R0)

Publish with us

Policies and ethics